All topics / drug policy reform
Topic
You are reading the free Skim layer. Read unlocks the synthesis and sources.
Drug policy reform
1
episodes
1
thinkers
3h
of conversation
4
books & papers
2
terms defined
The neighbourhood: drug policy reform and the ideas it travels with. Drag to roam, click a star for the episode, click a neighbour to travel.
Drag to roam · scroll to zoom · click a neighbour to travel · click a star for the episode
From foundational to frontier
Climb the spectrum. The most accessible conversations come first.
Start here
ACCESSIBLECOREFRONTIER
The lexicon
Every term the guests lean on, in plain language. Read one in full, or filter to find it.
What the corpus says
The throughline across every conversation that touches this idea.
MAPS has raised about $110 million over 35 years to integrate psychedelics into therapeutic practices.
Rick Doblin · Rick Doblin: Psychedelics
MDMA-assisted therapy shows a 67% PTSD remission rate for the dissociative subtype, outperforming traditional therapies.
Rick Doblin · Rick Doblin: Psychedelics
The FDA is expected to approve MDMA for PTSD treatment by the end of 2023, marking a milestone in psychedelic therapy.
Rick Doblin · Rick Doblin: Psychedelics
MDMA enhances memory processing by reducing amygdala activity and increasing connectivity with the hippocampus.
Rick Doblin · Rick Doblin: Psychedelics
The backlash against psychedelics in the 60s was driven by their potential for social change, not just negative experiences.
Rick Doblin · Rick Doblin: Psychedelics
Voices on drug policy reform
4 standout quotes from across the corpus.
Go read
4 books and papers cited across these episodes.
For the specialist
What experts find new
2 expert-level takeaways for a specialist reader.
At the frontier
Still unresolved
1 open questions flagged across these conversations.
The thinkers
Who takes this idea on, by how often they return to it.